SUPPLEMENT

Q1 2020 — Condensed Consolidated Statement of Earnings

Q1 2020PDF · 1 pages19 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	20,691	$ 	100.0 	20,021	$ 	100.0 	3.3
Cost of products sold 	7,062 	34.1 	6,615 	33.0 	6.8
Gross Profit 	13,629 	65.9 	13,406 	67.0 	1.7
Selling, marketing and administrative expenses 	5,203 	25.1 	5,219 	26.1 	(0.3)
Research and development expense 	2,580 	12.5 	2,858 	14.3 	(9.7)
In-process research and development 	- 	- 	890 	4.4
Interest (income) expense, net 	(42) 	(0.2) 	3 	0.0
Other (income) expense, net 	(679) 	(3.3) 	(22) 	(0.1)
Restructuring 	58 	0.3 	36 	0.2
Earnings before provision for taxes on income 	6,509 	31.5 	4,422 	22.1 	47.2
Provision for taxes on income 	713 	3.5 	673 	3.4 	5.9
Net earnings 	5,796 	28.0 	3,749 	18.7 	54.6
Net earnings per share (Diluted) 	2.17	$ 	1.39	$ 	56.1
Average shares outstanding (Diluted) 	2,671.0 	2,698.8
Effective tax rate 	11.0 % 	15.2 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	7,244	$ 	35.0 	6,867	$ 	34.3 	5.5
Net earnings 	6,154	$ 	29.7 	5,661	$ 	28.3 	8.7
Net earnings per share (Diluted) 	2.30	$ 	2.10	$ 	9.5
Effective tax rate 	15.0 % 	17.6 %
(1) See Reconciliation of Non-GAAP Financial Measures.
FIRST QUARTER
2020 	2019

-- 1 of 1 --